Mike Nicholson

Mike Nicholson is President and COO at Inceptor Bio. Prior to Inceptor Bio, Dr. Nicholson spent nearly 13 years at Precision BioSciences, where he held several leadership roles, including Executive Director of Scientific Operations, Vice President of R&D, and Senior Vice President of Research. Dr. Nicholson played a key role in developing Precision’s novel gene-editing platform and led research teams focused on allogeneic CAR T therapies and gene-editing-based gene therapies. Dr. Nicholson earned his BS in chemistry from SUNY Brockport, his Ph.D. in molecular biology and genetics from the Johns Hopkins School of Medicine, and carried out postdoctoral research at the University of North Carolina, Chapel Hill.